Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels

Journal of Rheumatology

Volumn 38, Issue 9, 2011, Pages 1994-1999

  Myles, Arpita ^a   Viswanath, Vishad ^a   Singh, Yogesh Preet ^a   Aggarwal, Amita ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Disease activity; Inflammation; Juvenile arthritis; Receptor for advanced glycation endproducts

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; PROTEIN S 100; PROTEIN S100A12; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTHRITIS; ARTICLE; BLOOD LEVEL; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; ENTHESITIS; ENTHESITIS RELATED ARTHRITIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; JOINT SWELLING; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REACTIVE ARTHRITIS; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SYNOVIAL FLUID LEVEL;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; FEMALE; HUMANS; INFANT; INFLAMMATION MEDIATORS; MALE; PREDICTIVE VALUE OF TESTS; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; YOUNG ADULT;

EID: 80052324298     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110058     Document Type: Article

References (25)

1. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001;108:949-955 (Pubitemid 32946067)
2. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 2000;1498:99-111.
3. Sparvero L.J., Asafu-Adjei D., Kang R., Tang D., Amin N., Im J., et al. RAGE (receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 2009;7:17-38.
4. Lin Li, Park S., Lakatta EG. RAGE signaling in inflammation and arterial aging. Front Biosci 2009;14:1403-1413
5. Chavakis T., Bierhaus A., Al-Fakhri N., Schneider D., Witte S., Linn T., et al. The pattern recognition receptor (RAGE) is a counter receptor for leukocyte integrins:A novel pathway for inflammatory cell recruitment. J Exp Med 2003;198:1507-1515 (Pubitemid 37467165)
6. Pullerits R., Brisslert M., Jonsson I.M., Tarkowski A. Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta 2 integrin Mac-1. Arthritis Rheum 2006;54:3898-3907 (Pubitemid 44955893)
7. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1999;1450:191-231. (Pubitemid 29295473)
8. Wittkowski H., Frosch M., Wulffraat N., Goldbach-Mansky R., Kallinich T., Kuemmerle-Deschner J., et al. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum 2008;58:3924-3931
9. Foell D., Wittkowski H., Roth J. Mechanisms of disease:A 'DAMP'view of inflammatory arthritis. Nat Clin Pract Rheumatol 2007;3:382-390 (Pubitemid 47034539)
10. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., et al. RAGE mediates a novel proinflammatory axis:A central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889-901. (Pubitemid 29375048)
11. Pullerits R., Bokarewa M., Dahlberg L., Tarkowski A. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 2005;7:R817-R824
12. Chayanupatkul M., Honsawek S. Soluble receptor for advanced glycation end products (sRAGE) in plasma and synovial fluid is inversely associated with disease severity of knee osteoarthritis. Clin Biochem 2010;43:1133-1137
13. Stewart C., Cha S., Caudle R.M., Berg K., Katz J. Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjögren's syndrome. Rheumatol Int 2008;28:771-776
14. Wittkowski H., Hirono K., Ichida F., Vogl T., Ye F., Yanlin X., et al. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12. Arthritis Rheum 2007;56:4174-4181 (Pubitemid 350262345)
15. Chen Y.S., Yan W., Geczy G.L., Brown M.A., Thomas R. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis. Arthritis Res Ther 2009;11:R39-R50
16. Petty R.E., Southwood T.R., Manners P., Baum J., Glass D.N., Goldenberg J., et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis:Second revision, Edmonton, 2001. J Rheumatol 2004;31:390-392 (Pubitemid 38160763)
17. Foell D., Wittkowski H., Hammerschmidt I., Wulffraat N., Schmeling H., Frosch M., et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum 2004;50:1286-1295 (Pubitemid 38480840)
18. Baillet A., Trocmé C., Berthier S., Arlotto M., Grange L., Chenau J., et al. Synovial fluid proteomic fingerprint:S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology 2010;49:671-682
19. Sunahori K., Yamamura M., Yamana J., Takasugi K., Kawashima M., Makino H. Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 2006;54:97-104. (Pubitemid 43122192)
20. Hou F.F., Jiang J.P., Guo J.Q., Wang G.B., Zhang X., Stern D.M., et al. Receptor for advanced glycation end products on human synovial fibroblasts:Role in the pathogenesis of dialysis-related amyloidosis. J Am Soc Nephrol 2002;13:1296-1306 (Pubitemid 34441411)
21. Tolboom T.C., Pieterman E., Van der Laan W.H., Toes R.E., Huidekoper A.L., Nelissen R.G., et al. Invasive properties of fibroblast-like synoviocytes:Correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis 2002;61:975-980 (Pubitemid 35221685)
22. Pullerits R., Bokarewa M., Dahlberg L., Tarkowski A. Synovial fluid expression of autoantibodies specific for RAGE relates to less erosive course of rheumatoid arthritis. Rheumatology 2007;46:1367-1371 (Pubitemid 47244516)
23. Ferrante E., Vazzana N., Santilli F., Di Cicco M., Lauriti C., Di Battista L., et al. Determinants of thromboxane biosynthesis in rheumatoid arthritis:Role of RAGE and oxidant stress. Free Radic Biol Med 2010;49:857-864
24. Ellis J.A., Munro J.E., Ponsonby A.E. Possible environmental determinants of juvenile idiopathic arthritis. Rheumatology 2010;49:411-425
25. Wang Y., Wang H., Piper M.G., McMaken S., Mo X., Opalek J., et al. sRAGE induces human monocyte survival and differentiation. J Immunol 2010;185:1822-1835